Annual report [Section 13 and 15(d), not S-K Item 405]

Statements of Cash Flows

v3.26.1
Statements of Cash Flows - USD ($)
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2025
Jun. 30, 2025
Sep. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Operating activities:          
Net loss $ (2,744,780) $ (6,493,420) $ (10,204,689) $ (19,358,218) $ (17,414,219)
Adjustments required to reconcile net loss to net cash used in operating activities:          
Amortization       1,779 3,612
Stock-based compensation       6,803,325 7,253,327
Changes in operating assets and liabilities:          
Accounts payable       2,071,543 2,546,629
Deferred compensation       367,538 306,281
Unreimbursed expenses (accrued)       200,580 37,827
Net cash used in operating activities (1,834,454) (4,067,557) (6,738,796) (9,913,453) (7,266,543)
Financing activities:          
Sale of common stock via ATM program, net of costs       11,854,484 1,869,111
Net proceeds from exercise of remaining underwriter warrants       145,000
Sale of common stock via Private Placement, net of costs       2,499,998
Net cash provided by financing activities       11,999,484 4,369,109
Net increase (decrease) in cash       2,086,031 (2,897,434)
Cash, beginning of period $ 4,091,990 $ 4,091,990 $ 4,091,990 4,091,990 6,989,424
Cash, end of period       $ 6,178,021 $ 4,091,990